The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice.
about
The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine-1-phosphate receptorsExperimental Diabetes Mellitus in Different Animal ModelsProlonging survival of corneal transplantation by selective sphingosine-1-phosphate receptor 1 agonistChronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes.Prevention, but not cure, of autoimmune diabetes in a NOD.scid transfer model by FTY720 despite effective modulation of blood T cells.Regulation of learning and memory by meningeal immunity: a key role for IL-4The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2.Effect of FTY720 on some physiological indexes of Non-Obese Diabetic (NOD) Mice.Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.From markers to molecular mechanisms: type 1 diabetes in the post-GWAS era.The role of sphingosine-1-phosphate and its receptors in asthma.The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases.The effect of immunomodulators on prevention of autoimmune diabetes is stage dependent: FTY720 prevents diabetes at three different stages in the diabetes-resistant biobreeding rat.Local delivery of fingolimod from three-dimensional scaffolds impacts islet graft efficacy and microenvironment in a murine diabetic model.Prominence of central sphingosine-1-phosphate receptor-1 in attenuating aβ-induced injury by fingolimod.Treatment with a sphingosine-1-phosphate analog inhibits airway remodeling following repeated allergen exposure
P2860
Q24681206-FF93CF78-43D3-4991-A7B5-7282C44C351AQ28066824-A925C6D4-58F0-4EF1-8EC9-1F284C8208B8Q28542948-C35379E5-D2FE-4D27-B608-7EC905C8B244Q30427148-CF2B1DFF-5062-4BF8-8EEF-C46B86A99F19Q30428016-87D029E0-B9B6-4B59-8ACA-5A91A8625A53Q30434189-9E6FC412-89F7-4652-B9CD-E816CFD9481FQ34274256-A542CBC0-C6B8-4188-AB5E-6716AD5CBE31Q36057311-C57FF7A5-5DD7-41F8-9B42-70671DD57DB6Q36861002-4F336187-3141-4FDE-9304-7AB1BDEEB16FQ37088194-DB7B5982-B71A-435D-9E1D-FDCE064E60C7Q37128721-6AC1B47F-12BB-4364-904F-024C9BE73445Q39021621-B3407EF9-9F01-49B5-B4D9-F61209FE1266Q44813941-0D62341B-4BCE-46A0-AD67-A450D3B75183Q48169015-56BD4D98-C35D-407A-8E1E-6B3CFB4D3EBEQ48529387-91B4E632-A55C-422F-8223-9CB2F61F7825Q57012316-39274CF0-D951-467B-99FB-517BDB616CB4
P2860
The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice.
@ast
The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice.
@en
type
label
The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice.
@ast
The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice.
@en
prefLabel
The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice.
@ast
The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice.
@en
P2093
P1433
P1476
The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice.
@en
P2093
Jerry L Nadler
Justin D Ellett
Kevin R Lynch
Lawrence B Fialkow
Volker Brinkmann
Zandong Yang
P356
10.1016/S1521-6616(02)00054-2
P577
2003-04-01T00:00:00Z